Dr. Peter R. Seidensticker, MD - Vice President MCA, Modality Head CT / CV & Informatics - Bayer Pharmaceuticals | LinkedIn
![16 June 2019, Hessen, Wiesbaden: Gisela Reinhold, music educator and organizer, stands in the Staatstheater. The baby concerts in the state capital are intended for children up to the age of three. 16 June 2019, Hessen, Wiesbaden: Gisela Reinhold, music educator and organizer, stands in the Staatstheater. The baby concerts in the state capital are intended for children up to the age of three.](https://c8.alamy.com/comp/TDHEDP/16-june-2019-hessen-wiesbaden-cdu-candidate-eberhard-seidensticker-looks-at-the-count-results-so-far-the-spd-and-cdu-candidates-will-run-for-the-office-of-mayor-in-the-second-ballot-in-the-first-round-of-elections-on-26-may-both-were-able-to-assert-themselves-against-five-candidates-photo-andreas-arnolddpa-TDHEDP.jpg)
16 June 2019, Hessen, Wiesbaden: Gisela Reinhold, music educator and organizer, stands in the Staatstheater. The baby concerts in the state capital are intended for children up to the age of three.
Dr. Peter R. Seidensticker, MD - Vice President MCA, Modality Head CT / CV & Informatics - Bayer Pharmaceuticals | LinkedIn
![PDF) Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib PDF) Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib](https://i1.rgstatic.net/publication/357605597_Early_tumor_shrinkage_and_response_assessment_according_to_mRECIST_predict_overall_survival_in_hepatocellular_carcinoma_patients_under_sorafenib/links/61d60d35e669ee0f5c8a4859/largepreview.png)
PDF) Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
![Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine](https://www.researchgate.net/publication/357605597/figure/fig1/AS:1109001827811330@1641418048623/Overall-survival-of-patients-with-compared-to-patients-without-objective-response-CI_Q320.jpg)
Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine
![Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine](https://www.researchgate.net/publication/357605597/figure/fig2/AS:1109001827811331@1641418048702/Overall-survival-of-patients-with-ETS-20-vs-ETS-20-CI-confidence-interval-ETS_Q320.jpg)
Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine
![PDF) Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma PDF) Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma](https://i1.rgstatic.net/publication/293045147_Extensive_Use_of_Interventional_Therapies_Improves_Survival_in_Unresectable_or_Recurrent_Intrahepatic_Cholangiocarcinoma/links/56d83c4608aebe4638b44c71/largepreview.png)